Literature DB >> 9353694

Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.

O Borgå1, B Borgå.   

Abstract

The unbound fraction in serum, fu, is a critical parameter in describing and understanding the pharmacokinetics of NSAIDs. We compared fu for 6 different NSAIDs using ultrafiltration of pooled serum at pH 7.4 and 24C. Measurements covered a wide concentration range in order to define binding affinity and number of binding sites. HPLC was used to measure drug concentrations in serum and ultrafiltrate. Direct injection of ultrafiltrate and serum (diluted 250 x) permitted quantitation down to approximately 70 nM for most of the NSAIDs, i.e., approximately 15-20 ng/ml. Assuming binding only to albumin, the data were fitted to a model of two classes of binding sites with dissociation constants K1 and K2. The lowest K1 (highest affinity) was found with flurbiprofen, 0.0658 microM, the highest with ketoprofen, 5.23 microM, an 80-fold difference. At low drug concentrations, fu becomes virtually constant and approaches a lower limit, fumin. The following fumin values were calculated: diclofenac 0.21%; fenoprofen 0.25%, flurbiprofen 0.022%, ketoprofen 0.52%, naproxen 0.039%, and tolmetin 0.37%. Thus the least bound NSAID, ketoprofen, had a value 24-fold that of the most highly bound, flurbiprofen. The NSAIDs also differed widely with regard to the extent of variation in fu within the range of therapeutic concentrations, and hence with regard to their potential as displacers of other drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353694     DOI: 10.1023/a:1025719827072

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  37 in total

1.  Determination of free concentration of piroxicam and naproxen in plasma. The influence of experimental conditions in equilibrium dialysis.

Authors:  O Hundal; H E Rugstad
Journal:  Fundam Clin Pharmacol       Date:  1991       Impact factor: 2.748

2.  Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren.

Authors:  W Riess; H Stierlin; P Degen; J W Faigle; A Gérardin; J Moppert; A Sallmann; K Schmid; A Schweizer; M Sulc; W Theobald; J Wagner
Journal:  Scand J Rheumatol Suppl       Date:  1978

3.  The determination of naproxen by spectrofluorometry and its binding to serum proteins.

Authors:  A Mortensen; E B Jensen; P B Petersen; S Husted; F Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-04

4.  Nonlinear plasma level response to high doses of naproxen.

Authors:  R Runkel; E Forchielli; H Sevelius; M Chaplin; E Segre
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

5.  Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.

Authors:  O G Nilsen; L Storstein; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1977-02-01       Impact factor: 5.858

6.  Kinetics of drug displacement interactions.

Authors:  L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

7.  The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man.

Authors:  V A John
Journal:  Rheumatol Rehabil       Date:  1979

8.  A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium.

Authors:  J V Willis; M J Kendall; D B Jack
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

9.  Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

Authors:  L Aarons; R Salisbury; M Alam-Siddiqi; L Taylor; D M Grennan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

10.  In vitro protein binding of diclofenac sodium in plasma and synovial fluid.

Authors:  K K Chan; K H Vyas; K D Brandt
Journal:  J Pharm Sci       Date:  1987-02       Impact factor: 3.534

View more
  18 in total

1.  Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal.

Authors:  Leonid M Berezhkovskiy
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-07-14       Impact factor: 2.745

2.  Studies on the interaction of tricyclazole with beta-cyclodextrin and human serum albumin by spectroscopy.

Authors:  Hua-Xin Zhang; Xing Huang; Ping Mei; Ke-Hua Li; Cheng-Nong Yan
Journal:  J Fluoresc       Date:  2006-05-16       Impact factor: 2.217

Review 3.  Noncovalent labeling of biomolecules with red and near- infrared dyes.

Authors:  Gabor Patonay; Jozef Salon; John Sowell; Lucjan Strekowski
Journal:  Molecules       Date:  2004-02-28       Impact factor: 4.411

4.  Computational prediction of CNS drug exposure based on a novel in vivo dataset.

Authors:  Christel A S Bergström; Susan A Charman; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2012-06-29       Impact factor: 4.200

5.  Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin.

Authors:  D Shcharbin; B Klajnert; V Mazhul; M Bryszewska
Journal:  J Fluoresc       Date:  2005-01       Impact factor: 2.217

6.  Differential effects of anti-cancer and anti-hepatitis drugs on liver cystatin.

Authors:  Aaliya Shah; Medha Priyadarshini; Mohd Shahnawaz Khan; Mohammad Aatif; Fakhra Amin; Shams Tabrez; Galila F Zaher; Bilqees Bano
Journal:  Saudi J Biol Sci       Date:  2014-07-05       Impact factor: 4.219

7.  Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers.

Authors:  Dymphy R H Huntjens; David J M Spalding; Meindert Danhof; Oscar E Della Pasqua
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

8.  Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2017-02-28       Impact factor: 3.922

9.  Effects of 2-amino-8-hydroxyquinoline interaction on the conformation of physiological isomers of human serum albumin.

Authors:  Sonali M Shiriskar; Neeraj Agarwal; Raghuvir R S Pissurlenkar; Basir Ahmad
Journal:  Eur Biophys J       Date:  2015-03-12       Impact factor: 1.733

10.  Thermodynamic studies on the interaction of dioxopromethazine to beta-cyclodextrin and bovine serum albumin.

Authors:  Hua-Xin Zhang; Xing Huang; Min Zhang
Journal:  J Fluoresc       Date:  2008-02-23       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.